KR20060135959A - 발사르탄 및 이의 전구체의 제조방법 - Google Patents

발사르탄 및 이의 전구체의 제조방법 Download PDF

Info

Publication number
KR20060135959A
KR20060135959A KR1020067024308A KR20067024308A KR20060135959A KR 20060135959 A KR20060135959 A KR 20060135959A KR 1020067024308 A KR1020067024308 A KR 1020067024308A KR 20067024308 A KR20067024308 A KR 20067024308A KR 20060135959 A KR20060135959 A KR 20060135959A
Authority
KR
South Korea
Prior art keywords
formula
compound
group
valsartan
valine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020067024308A
Other languages
English (en)
Korean (ko)
Inventor
벨문뜨 호르디 베싸
끌로떼뜨 호안 우게뜨
안드레쓰 후안 안또니오 뻬레쓰
바르호안 뻬레 달마쎄쓰
Original Assignee
인케, 에스.아.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 인케, 에스.아. filed Critical 인케, 에스.아.
Publication of KR20060135959A publication Critical patent/KR20060135959A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
KR1020067024308A 2004-04-20 2005-04-18 발사르탄 및 이의 전구체의 제조방법 Ceased KR20060135959A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200400949A ES2251292B1 (es) 2004-04-20 2004-04-20 Procedimiento para la obtencion de un compuesto farmaceuticamente activo y de sus intermedios de sintesis.
ES200400949 2004-04-20

Publications (1)

Publication Number Publication Date
KR20060135959A true KR20060135959A (ko) 2006-12-29

Family

ID=34966329

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067024308A Ceased KR20060135959A (ko) 2004-04-20 2005-04-18 발사르탄 및 이의 전구체의 제조방법

Country Status (13)

Country Link
US (1) US7728021B2 (https=)
EP (1) EP1747190B1 (https=)
JP (1) JP2007533727A (https=)
KR (1) KR20060135959A (https=)
AT (1) ATE401300T1 (https=)
DE (1) DE602005008224D1 (https=)
ES (2) ES2251292B1 (https=)
PL (1) PL1747190T3 (https=)
PT (1) PT1747190E (https=)
SI (1) SI1747190T1 (https=)
TW (1) TWI283576B (https=)
WO (1) WO2005102987A1 (https=)
ZA (1) ZA200608986B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101012135B1 (ko) * 2008-12-18 2011-02-07 주식회사 대희화학 발사르탄 메틸 에스테르의 제조방법

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1618097A1 (en) 2003-04-21 2006-01-25 Teva Pharmaceutical Industries Ltd Process for the preparation of valsartan
EP1838681A2 (en) * 2004-12-22 2007-10-03 Enantia, S.L. Intermediate compounds for the preparation of an angiotensin ii receptor and process for the preparation of valsartan
ES2259909B1 (es) 2005-02-28 2007-06-16 Inke, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo y de su intermedio de sintesis.
WO2007005967A2 (en) * 2005-07-05 2007-01-11 Teva Pharmaceutical Industries Ltd. Process for preparing valsartan
ITMI20051989A1 (it) * 2005-10-20 2007-04-21 Dipharma Spa Procedimerntyo per la preparazione di composti antagonisti di angiotensina ii
ES2288376B1 (es) * 2005-10-20 2008-11-01 Inke, S.A. Procedimiento para la obtencion de intermedios utiles en la obtencion de un compuesto farmaceuticamente activo.
WO2007071750A1 (en) * 2005-12-22 2007-06-28 Enantia, S.L. Intermediates and processes for the preparation of valsartan
ES2300175B1 (es) * 2006-02-14 2009-06-08 Inke, S.A. Procedimiento para la obtencion de intermedios utiles en la obtencion de un compuesto farmaceuticamente activo.
WO2008007391A2 (en) * 2006-07-10 2008-01-17 Manne Satyanarayana Reddy An improved process for the preparation of valsartan
EP1849777B1 (en) * 2007-06-07 2008-10-29 Inke, S.A. Process for obtaining a valsartan salt useful for obtaining valsartan
US8492577B2 (en) 2008-04-07 2013-07-23 Hetero Research Foundation Process for preparation of valsartan intermediate
CN102702118B (zh) * 2012-06-11 2014-04-16 吉林三善恩科技开发有限公司 一种缬沙坦有机药物共晶及其制备方法
CN103804313B (zh) * 2014-01-27 2015-12-09 云南现代民族药工程技术研究中心 一种简洁的低成本高效率制备缬沙坦的方法
US9687475B1 (en) 2016-03-24 2017-06-27 Ezra Pharma Llc Extended release pharmaceutical formulations with controlled impurity levels
US9675585B1 (en) 2016-03-24 2017-06-13 Ezra Pharma Extended release pharmaceutical formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000050I1 (de) 1990-02-19 2007-11-08 Novartis Ag Acylverbindungen
DE4319040A1 (de) 1992-10-23 1994-04-28 Bayer Ag Alkoxymethylsubstituierte Pyridonbiphenyle
DE4319041A1 (de) * 1992-10-23 1994-04-28 Bayer Ag Trisubstituierte Biphenyle
DE4313747A1 (de) * 1993-04-27 1994-11-03 Bayer Ag Verfahren zur Herstellung von substituierten Biphenyltetrazolen
DE4320432A1 (de) * 1993-06-21 1994-12-22 Bayer Ag Substituierte Mono- und Bipyridylmethylderivate
DE4407488A1 (de) 1994-03-07 1995-09-14 Bayer Ag Verwendung von Biphenyl- und Pyridylmethylpyridonen
DE69507887T2 (de) 1994-09-20 1999-06-17 Wakunaga Seiyaku K.K., Osaka Verfahren zur herstellung von n-biphenylmethylthiadiazolin derivaten oder deren salzen sowie dafür benötigte zwischen verbindungen
US6207665B1 (en) * 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
ATE277913T1 (de) * 2001-01-19 2004-10-15 Pharmacopeia Inc Bisarylderivate mit fsh rezeptor modulierender aktivität
GB0121033D0 (en) * 2001-08-30 2001-10-24 Novartis Ag Organic compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101012135B1 (ko) * 2008-12-18 2011-02-07 주식회사 대희화학 발사르탄 메틸 에스테르의 제조방법

Also Published As

Publication number Publication date
SI1747190T1 (sl) 2008-12-31
WO2005102987A1 (en) 2005-11-03
ES2251292A1 (es) 2006-04-16
PT1747190E (pt) 2008-09-29
US20090221836A1 (en) 2009-09-03
ZA200608986B (en) 2008-02-27
EP1747190A1 (en) 2007-01-31
TWI283576B (en) 2007-07-11
PL1747190T3 (pl) 2009-01-30
DE602005008224D1 (de) 2008-08-28
ES2251292B1 (es) 2007-07-01
EP1747190B1 (en) 2008-07-16
ES2309741T3 (es) 2008-12-16
US7728021B2 (en) 2010-06-01
JP2007533727A (ja) 2007-11-22
TW200539873A (en) 2005-12-16
ATE401300T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
KR20060135959A (ko) 발사르탄 및 이의 전구체의 제조방법
JP2012184243A (ja) ２，３−ジ置換インドール類の製造方法
JP3586288B2 (ja) ビフェニル誘導体の製法
JP2007533727A5 (https=)
JP4139334B2 (ja) 新規ボロネートエステル
JP2008088172A (ja) フェニルテトラゾール化合物の製法
CN108148070B (zh) 一种呋喃酮并异喹啉酮类化合物的合成方法
JP2007112800A (ja) アンジオテンシンｉｉ拮抗化合物の製造方法
CN118084831A (zh) 四取代呋喃类化合物及其制备方法
CN1800179A (zh) 一种制备坎地沙坦的方法
JP3697045B2 (ja) β−ヒドラジノエステル類並びにピラゾリジノン類、ピラゾロン類およびβ−アミノ酸誘導体の製造方法
KR102246226B1 (ko) 로잘탄 대사체 exp-3174의 제조방법
JP5033933B2 (ja) Ｎ−置換−２−アミノ−４−（ヒドロキシメチルホスフィニル）−２−ブテン酸の製造法
CN103044313B (zh) 一种合成咔唑类化合物的方法
JP6909096B2 (ja) 触媒、アミド結合の形成方法、及びアミド化合物の製造方法
JP4951250B2 (ja) イミダゾール系化合物−パラジウム錯体触媒および同触媒を用いる芳香族オレフィン化合物の製造方法
JP5230609B2 (ja) Ａｃｅ阻害薬の合成における新規な医薬中間体及びその使用
JPS6325589B2 (https=)
JP2011057575A (ja) ４−ヒドロキシベンゾチオフェン誘導体の製造方法
WO2005063678A1 (ja) フェニル酢酸誘導体の製造方法
KR100795589B1 (ko) 2-부틸-4-클로로-1-[[2'-(1ｈ-테트라졸-5-일)바이페닐-4-일]메틸]이미다졸-5-카르복스알데하이드의 제조방법
WO2000029369A1 (fr) Derives d'acide aminoacrylique et procede de production correspondant
JP2009512661A (ja) 医薬活性化合物を得るのに有用なバリン誘導体を得る方法
JP3323917B2 (ja) インドール化合物の製造方法
HU226806B1 (en) Method of manufacturing the cycloheptimidazole derivatives and the used intermediates

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20061120

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20100419

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20111118

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20120510

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20111118

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I